CHM.CN Waverunner Capital Inc. (CNQ) rises 900% to C$0.05 27 Mar 2026: Key signals

CHM.CN stock jumped 900.00% to C$0.05 during market hours on 27 Mar 2026, moving from a previous close of C$0.005. The move put market cap at roughly C$37,211,650.00 on the Canada (CNQ) exchange and created a high-volume mover signal for traders watching small-cap healthcare names. Liquidity remains thin versus the 50-day average price of C$0.04, so intraday spikes can be amplified. This update focuses on what drove the move, the financial profile, and what investors should watch next.

CHM.CN stock intraday move and volume context

Today CHM.CN stock rose from C$0.005 to C$0.05, a 900.00% gain versus the prior close. The reported average volume is 28,908 shares, but current session prints show outsized trading relative to the average, a hallmark of high-volume movers during market hours. Low previous liquidity and a large share count of 744,233,000 shares outstanding can produce rapid price swings even on modest absolute flows.

CHM.CN stock fundamentals and valuation metrics

Waverunner Capital Inc. (CHM.CN) is listed on CNQ in Canada and is classified in Healthcare and Drug Manufacturers – Specialty & Generic. Key metrics: market cap C$37,211,650.00, EPS -0.01, reported PE -5.00, 50-day average price C$0.04, 200-day average price C$0.05. The company shows negative book value per share -0.14 and operating cash flow per share -0.03, signalling limited near-term free cash flow.

CHM.CN stock technicals and trading risks

Price action shows a one-day high and low at C$0.05, reflecting the current quoted range. Price volatility is extreme: one-year change was 400.00% while longer-term returns are negative. Short-term traders should note the gap from previous close and the thin displayed liquidity. The low current ratio 0.10 and negative cash flow per share increase solvency and dilution risk for long-term holders.

Meyka AI grade and model forecast for CHM.CN stock

Meyka AI rates CHM.CN with a score out of 100: 64.79 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 comparisons, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a base case target of C$0.07, a bull case of C$0.12, and a bear case of C$0.03 versus the current C$0.05. The base case implies +40.00% upside; the bull case implies +140.00% upside; the bear case implies -40.00% downside. Forecasts are model-based projections and not guarantees.

Sector view and catalysts affecting CHM.CN stock

CHM.CN sits in the Healthcare sector, which is down 5.64% YTD. Sector weakness increases sensitivity for small-cap healthcare ventures. Catalysts that could sustain momentum include announced financings, asset sales, or new investments in renewable energy and biotech holdings as noted in company filings. Absence of confirmed volume data or a clear news release increases the chance the move is speculative.

Practical strategy and watchlist items for CHM.CN stock

For traders, treat CHM.CN as a high-volatility, low-liquidity ticker and size positions accordingly. Watch for: official company news, insider filings, volume confirmatory prints above 28,908 average, and any financing or corporate-update filings. For investors, monitor quarterly reporting and cash runway before adding exposure. Always expect sharp intraday reversals on symbols with large outstanding share bases.

Final Thoughts

CHM.CN stock attracted attention on 27 Mar 2026 after a 900.00% intraday rise to C$0.05 on the CNQ exchange in Canada. The move reflects the classic pattern of a thinly traded small-cap with a large share base and limited free cash flow. Meyka AI’s model projects a base-target of C$0.07 (implied +40.00%), a bull target of C$0.12 (implied +140.00%), and a bear target of C$0.03 (implied -40.00%). Meyka AI rates CHM.CN 64.79/100 (Grade B, Suggestion: HOLD) based on sector and financial metrics. These forecasts are model-based projections and not guarantees. Key takeaways: expect continued volatility, prioritise confirmed corporate news and volume above the 28,908 average, and control position size because solvency and liquidity metrics remain weak. Use stop levels and verify filings before acting on momentum in this Healthcare small-cap.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.